Welcome to LookChem.com Sign In|Join Free

CAS

  • or

100129-12-2

Post Buying Request

100129-12-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

100129-12-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 100129-12-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,0,1,2 and 9 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 100129-12:
(8*1)+(7*0)+(6*0)+(5*1)+(4*2)+(3*9)+(2*1)+(1*2)=52
52 % 10 = 2
So 100129-12-2 is a valid CAS Registry Number.

100129-12-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 2-amino-3-(4-bromophenyl)propanoate

1.2 Other means of identification

Product number -
Other names 4-bromo-phenylalanine ethyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:100129-12-2 SDS

100129-12-2Relevant articles and documents

IMIDAZOPYRAZINE DERIVATIVES, PROCESS FOR PREPARATION THEREOF, AND THEIR USES AS LUCIFERINS

-

Page/Page column 60; 63, (2018/11/22)

The present invention is in the field of bioluminescence in biology and/or medicine. In particular, the invention provides imidazopyrazine derivatives, processes for preparation thereof, and their uses as luciferins.

SELECTIVE HDAC1,2 INHIBITORS

-

Paragraph 0324; 0325; 0326, (2018/06/04)

Provided herein are compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat diseases or disorders associated with HDAC1 and/or HDAC2 activity.

Pd-catalyzed directed ortho -C-H alkenylation of phenylalanine derivatives

García-Rubia, Alfonso,Laga, Eduardo,Cativiela, Carlos,Urriolabeitia, Esteban P.,Gómez-Arrayás, Ramón,Carretero, Juan C.

, p. 3321 - 3331 (2015/03/30)

A practical Pd-catalyzed ortho-olefination of enantioenriched N-(SO2Py)-protected aryl-alanine and norephedrine derivatives with electron-deficient alkenes has been developed using N-fluoro-2,4,6-trimethylpyridinium triflate as the terminal oxidant. The reaction occurs efficiently with excellent monosubstitution selectivity and without loss of enantiopurity. This cross-coupling proved to be broad in scope, tolerating a variety of steric and electronic changes to both coupling partners. Removal of the directing group under mild conditions provides access to optically active tetrahydroisoquinoline-3-carboxylic acid derivatives (Tics) with good diastereocontrol and with very small erosion of enantiomeric purity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 100129-12-2